Skip to main content
WHANIN PHARM CO.,LTD logo

WHANIN PHARM CO.,LTD — Investor Relations & Filings

Ticker · 016580 ISIN · KR7016580003 KO Manufacturing
Open in API
Filings indexed 179 across all filing types
Latest filing 2024-11-01 Earnings Release
Country KR South Korea
Listing KO 016580

About WHANIN PHARM CO.,LTD

https://www.whanin.com/?lang=eng

WHANIN PHARM CO.,LTD. is a pharmaceutical company that develops, manufactures, and sells a range of therapeutic products. The company specializes in medications for the Central Nervous System (CNS), with a particular focus on neuropsychiatric treatments such as anti-psychotics and CNS stimulants. In addition to its core CNS portfolio, Whanin Pharm's product line includes pharmaceuticals for the cardiovascular and gastrointestinal systems, antibiotics, and vitamin supplements. The company also provides development and manufacturing services for finished drug formulations.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Hwanin Pharmaceutical. It provides key financial highlights (revenue, operating profit, net income) for the third quarter of 2024 compared to previous periods. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). 9M 2024
2024-11-01 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Whan In Pharm Co., Ltd., covering the period from 2024.01.01 to 2024.06.30. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which is characteristic of an interim/quarterly report. It is not an announcement of a report, but the report itself. H1 2024
2024-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Hwanin Pharmaceutical. It provides key financial highlights (revenue, operating profit, net income) for the second quarter of 2024. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q2 2024
2024-07-30 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Whan In Pharm Co., Ltd. for the period ending March 31, 2024. It contains detailed financial statements, management discussion, and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Hwanin Pharmaceutical. It provides key financial highlights (revenue, operating profit, net income) for the first quarter of 2024 compared to previous periods. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q1 2024
2024-04-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM) for Hwanin Pharmaceutical, dated 2024-03-22. It details the approval of financial statements, dividend declarations, and the election of directors and audit committee members. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it provides the official outcome of shareholder votes.
2024-03-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.